FDA GLP-1 Suicide Warning Removal: What This Major Update Means for Weight Loss Treatments The U.S. Food and Drug Administration has officially requested the FDA GLP-1 suicide warning removal from the labels of several popular GLP-1 receptor agonist medications. This important change comes after a comprehensive review of clinical trials and real-world evidence found no…
Read more
FDA GLP-1 Suicide Warning Removal: What It Means for Weight Loss Drugs
